Quanterix
Quanterix Revenues Almost Double in Q2
The company posted second quarter revenues of $25.4 million, up from $13.1 million in Q2 2020 and above the consensus Wall Street estimate of $23.4 million.
The researchers found that the blood-based marker, a key product for vendor Quanterix, could aid in the diagnosis and management of several diseases.
Quanterix Q1 Revenues up 73 Percent
The company posted Q1 revenues of $27.2 million, up from $15.7 million in Q1 2020 and above the consensus Wall Street estimate of $21.4 million.
GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock
The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.
Mar 10, 2021
Mar 2, 2021
Quanterix Q4 Revenues Up 64 Percent
Feb 12, 2021
Quanterix, WuXi AppTec to Open Joint Lab in Shanghai
Feb 4, 2021
Quanterix Prices $250M Public Stock Offering
Aug 7, 2020
Quanterix Prices $85M Public Stock Offering
May 6, 2020
Quanterix Q1 Revenues Up 27 Percent
Mar 9, 2020
Quanterix Q4 Revenues Up 46 Percent
Nov 6, 2019